Pharma Mar, S.A.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Pharma Mar, S.A. generated cash of -$13,446,000, which is less than the previous year. Cash used in financing activities reached the amount of -$32,137,000 last year. Net change in cash is therefore -$89,789,000.
Cash Flow
| 2014 | 22.10M | -22.31M | -5.70M |
|---|---|---|---|
| 2015 | 11.10M | -28.32M | 8.30M |
| 2016 | -8.41M | 13.77M | 1.29M |
| 2017 | -1.45M | 5.99M | 5.26M |
| 2018 | -16.34M | 22.25M | -7.25M |
| 2019 | -26.13M | 32.06M | -11.03M |
| 2020 | 278.94M | -119.00M | -73.82M |
| 2021 | 25.67M | 18.47M | -27.41M |
| 2022 | 38.32M | 10.87M | -13.37M |
| 2023 | -13.44M | -43.04M | -32.13M |
0RC6.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 149.81M | 113.34M | 96.21M | 17.63M | 22.74M | 24.08M | 14.29M | 7.62M | 16.55M | 22.45M |
Operating activities | ||||||||||
Net income | 1.13M | 43.79M | 95.12M | 145.60M | -23.32M | -7.68M | -22.86M | -24.69M | 5.90M | 14.39M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 5.75M | 5.9M | 5.58M | 7.21M | 6.05M | 6.86M | 7.05M | 7.24M | 6.28M | 5.26M |
Stock-based compensation expense | 297K | 393K | 339K | 274K | 265K | 0 | 476K | 303K | 308K | 0 |
| Deferred income tax benefit | 297K | 393K | 339K | 274K | 265K | 0 | 476K | 303K | 308K | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 1.78M | 21.61M | -26.76M | -12.63M | -16.52M | 0 | 22.65M | 0 | -3.16M | 0 |
Inventories | -11.54M | -17.21M | 1.39M | -3.03M | -2.41M | -2.02M | -1.74M | 832K | 1.41M | -2.17M |
Accounts payable | 1.82M | 1.78M | 7.18M | 4.65M | 5.49M | 0 | -1.73M | 0 | 0 | 0 |
Cash generated by operating activities | -13.44M | 38.32M | 25.67M | 278.94M | -26.13M | -16.34M | -1.45M | -8.41M | 11.10M | 22.10M |
Investing activities | ||||||||||
Purchases Of Investments | -314.32M | -219.19M | 0 | -116.00M | -70K | 0 | -27.66M | 0 | -19.03M | -12.80M |
Investments In Property Plant And Equipment | -15.95M | -8.85M | -7.80M | -3.00M | -3.91M | -2.37M | -4.66M | -6.09M | -9.22M | -10.17M |
Acquisitions Net | 0 | 11K | 0 | 0 | 33.38M | 21.25M | 4.66M | 0 | 0 | 0 |
Cash generated by investing activities | -43.04M | 10.87M | 18.47M | -119.00M | 32.06M | 22.25M | 5.99M | 13.77M | -28.32M | -22.31M |
Financing activities | ||||||||||
Common Stock Issued | 18.60M | 57.22M | 33.55M | 30.36M | 8.56M | 2.78M | 0 | 3.53M | 10.85M | 254K |
Payments for dividends | -11.68M | -11.76M | -10.87M | -8.81M | 0 | 0 | -19.94M | -20.14M | -34.86M | -31.06M |
Repurchases of common stock | -37.90M | -50.17M | -40.65M | -63.70M | -7.48M | -3.44M | -6.18M | -4.16M | -4.68M | -3.15M |
Repayments of term debt | -1.15M | -8.65M | -15.27M | -32.37M | -14.04M | -16.82M | 3.29M | -18.21M | -23K | -29.75M |
Cash used in financing activities | -32.13M | -13.37M | -27.41M | -73.82M | -11.03M | -7.25M | 5.26M | 1.29M | 8.30M | -5.70M |
Net Change In Cash | -89.78M | 36.46M | 17.13M | 78.57M | -5.10M | -1.34M | 9.79M | 6.66M | -8.92M | -5.90M |
Cash at end of period | 60.02M | 149.81M | 113.34M | 96.21M | 17.63M | 22.74M | 24.08M | 14.29M | 7.62M | 16.55M |